Last reviewed · How we verify

Measles, mumps, rubella vaccine

PATH · FDA-approved active Biologic

Measles, mumps, rubella vaccine is a Live attenuated vaccine Biologic drug developed by PATH. It is currently FDA-approved for Prevention of measles, Prevention of mumps, Prevention of rubella. Also known as: MMR, Priorix®.

The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses by exposing it to attenuated (weakened) forms of these pathogens.

The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses by exposing it to attenuated (weakened) forms of these pathogens. Used for Prevention of measles, Prevention of mumps, Prevention of rubella.

At a glance

Generic nameMeasles, mumps, rubella vaccine
Also known asMMR, Priorix®
SponsorPATH
Drug classLive attenuated vaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

The vaccine contains live attenuated strains of measles, mumps, and rubella viruses that replicate in the body but do not cause disease in immunocompetent individuals. This triggers both humoral (antibody-mediated) and cell-mediated immune responses, creating immunological memory. Upon exposure to wild-type virus, the primed immune system rapidly produces neutralizing antibodies and activates T cells to prevent infection or reduce disease severity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Measles, mumps, rubella vaccine

What is Measles, mumps, rubella vaccine?

Measles, mumps, rubella vaccine is a Live attenuated vaccine drug developed by PATH, indicated for Prevention of measles, Prevention of mumps, Prevention of rubella.

How does Measles, mumps, rubella vaccine work?

The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses by exposing it to attenuated (weakened) forms of these pathogens.

What is Measles, mumps, rubella vaccine used for?

Measles, mumps, rubella vaccine is indicated for Prevention of measles, Prevention of mumps, Prevention of rubella.

Who makes Measles, mumps, rubella vaccine?

Measles, mumps, rubella vaccine is developed and marketed by PATH (see full PATH pipeline at /company/path).

Is Measles, mumps, rubella vaccine also known as anything else?

Measles, mumps, rubella vaccine is also known as MMR, Priorix®.

What drug class is Measles, mumps, rubella vaccine in?

Measles, mumps, rubella vaccine belongs to the Live attenuated vaccine class. See all Live attenuated vaccine drugs at /class/live-attenuated-vaccine.

What development phase is Measles, mumps, rubella vaccine in?

Measles, mumps, rubella vaccine is FDA-approved (marketed).

What are the side effects of Measles, mumps, rubella vaccine?

Common side effects of Measles, mumps, rubella vaccine include Fever, Rash, Parotitis (mumps-like symptoms), Arthralgia/arthritis, Local injection site reactions.

Related